Alemtuzumab by Continuous Intravenous Infusion Followed by Subcutaneous Injection Plus Rituximab in the Treatment of Patients With Chronic Lymphocytic Leukemia Recurrence / Faderl, S., Ferrajoli, A., Wierda, W., O'Brien, S., Lerner, S., Keating, M.j.. - In: CANCER. - ISSN 0008-543X. - 116:10(2010), pp. 2360-2365. [10.1002/cncr.24958]
Alemtuzumab by Continuous Intravenous Infusion Followed by Subcutaneous Injection Plus Rituximab in the Treatment of Patients With Chronic Lymphocytic Leukemia Recurrence
Ferrajoli A;
2010
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


